,8 This mechanism was further supported by Quattrini et al, who reported 2 cases of dupilumab-induced psoriasis successfully treated with tralokinumab, suggesting that IL-4 inhibition alone was responsible for this paradoxical reaction.9 This evidence concerns the gene IL4 and psoriasis.